Novo Nordisk sues rival Eli Lilly over weight loss drug advertising

Summary

Drugmaker Novo Nordisk sued rival Eli Lilly on Tuesday, accusing the company of false advertising over the performance of its weight loss drugs.  The lawsuit, filed in federal district court in New Jersey, alleges Lilly intentionally selected outdated studies to show the use of Mounjaro and Zepbound lead to significantly more weight loss than Novo Nordisk’s Ozempic and…